RIPK1 and cholangiocarcinoma: RIPK1 represents a key mediator of TLR3 ligand and Smac mimetic induced both apoptosis and necroptosis in CCA cell lines, therefore investigation of RIPK1 in CCA patients became of great importance as an in vivo relevance for a potential therapeutic development.